Host PI(3,5)P2 activity is required for Plasmodium berghei growth during liver stage infection

Traffic

Volumn 15, Issue 10, 2014, Pages 1066-1082

  Thieleke Matos, Carolina ^a,b   da Silva, Mafalda Lopes ^a,b   Cabrita Santos, Laura ^a,b   Pires, Cristiana F ^a   Ramalho, José S ^a   Ikonomov, Ognian ^c   Seixas, Elsa ^a,b   Shisheva, Assia ^c   Seabra, Miguel C ^a,b,d   Barral, Duarte C ^a  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Liver stage infection; Malaria; PI(3,5)P2; PIKfyve; Plasmodium berghei; TRPML1

Indexed keywords

PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3,5 BISPHOSPHATE; PHOSPHOLIPID; UNCLASSIFIED DRUG; MCOLN1 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,5-DIPHOSPHATE; PIKFYVE PROTEIN, MOUSE; POLYPHOSPHOINOSITIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DISEASE COURSE; ENDOCYTOSIS; ENDOSOME; FEMALE; GROWTH; HOST CELL; HOST PARASITE INTERACTION; MALARIA; MEMBRANE FUSION; MOUSE; NONHUMAN; PARASITE; PARASITE DEVELOPMENT; PLASMODIUM; PLASMODIUM BERGHEI; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; LIVER; METABOLISM; PARASITE LOAD; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; ENDOCYTOSIS; LIVER; MICE; PARASITE LOAD; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PLASMODIUM BERGHEI; PROTEIN TRANSPORT; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84908503339     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12190     Document Type: Article

References (46)

1. WHO. World Malaria Report 2010. WHO [cited 2014 April 16]. Available from http://www.who.int/malaria/publications/atoz/9789241564106/en/
2. Amino R, Thiberge S, Blazquez S, Baldacci P, Renaud O, Shorte S, Ménard R. Imaging malaria sporozoites in the dermis of the mammalian host. Nat Protoc 2007;2:1705-1712.
3. Amino R, Thiberge S, Shorte S, Frischknecht F, Ménard R. Quantitative imaging of Plasmodium sporozoites in the mammalian host. C R Biol 2006;329:858-862.
4. Tarun AS, Baer K, Dumpit RF, Gray S, Lejarcegui N, Frevert U, Kappe SHI. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 2006;36:1283-1293.
5. Jayabalasingham B, Bano N, Coppens I. Metamorphosis of the malaria parasite in the liver is associated with organelle clearance. Cell Res 2010;20:1043-1059.
6. Mota MM, Pradel G, Vanderberg JP, Hafalla JCR, Frevert U, Nussenzweig RS, Nussenzweig V, Rodríguez A. Migration of plasmodium sporozoites through cells before infection. Science 2001;291:141-144.
7. Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok J-M, Menard R, Heussler VT. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006;313:1287-1290.
8. Derbyshire ER, Mota MM, Clardy J. The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog 2011;7:e1002178.
9. Nganou-Makamdop K, Sauerwein RW. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better? Trends Parasitol 2013;29:304-310.
10. Lopes da Silva M, Thieleke-Matos C, Cabrita-Santos L, Ramalho JS, Wavre-Shapton ST, Futter CE, Barral DC, Seabra MC. The host endocytic pathway is essential for Plasmodium berghei late liver stage development. Traffic 2012;13:1351-1363.
11. Deschermeier C, Hecht L-S, Bach F, Rützel K, Stanway RR, Nagel A, Seeber F, Heussler VT. Mitochondrial lipoic acid scavenging is essential for Plasmodium berghei liver stage development. Cell Microbiol 2012;14:416-430.
12. Bano N, Romano JD, Jayabalasingham B, Coppens I. Cellular interactions of Plasmodium liver stage with its host mammalian cell. Int J Parasitol 2007;37:1329-1341.
13. Grützke J, Rindte K, Goosmann C, Silvie O, Rauch C, Heuer D, Lehmann MJ, Mueller A-K, Brinkmann V, Matuschewski K, Ingmundson A. The spatiotemporal dynamics and membranous features of the plasmodium liver stage tubovesicular network. Traffic 2014;15:362-382.
14. Behnia R, Munro S. Organelle identity and the signposts for membrane traffic. Nature 2005;438:597-604.
15. Kutateladze TG. Translation of the phosphoinositide code by PI effectors. Nat Chem Biol 2010;6:507-513.
16. Mayinger P. Phosphoinositides and vesicular membrane traffic. Biochim Biophys Acta 2012;1821:1104-1113.
17. Ikonomov OC, Sbrissa D, Shisheva A. Localized PtdIns 3, 5-P2 synthesis to regulate early endosome dynamics and fusion. Am J Physiol Cell Physiol 2006;291:C393-C404.
18. Shisheva A. PIKfyve and its lipid products in health and in sickness. Curr Top Microbiol Immunol 2012;362:127-162.
19. Ho CY, Alghamdi TA, Botelho RJ. Phosphatidylinositol-3, 5-bisphosphate: no longer the poor PIP2. Traffic 2012;13:1-8.
20. Weber SS, Ragaz C, Hilbi H. Pathogen trafficking pathways and host phosphoinositide metabolism. Mol Microbiol 2009;71:1341-1352.
21. Wang Y, Weiss LM, Orlofsky A. Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem 2009;284:1694-1701.
22. Woolsey AM, Sunwoo L, Petersen CA, Brachmann SM, Cantley LC, Burleigh BA. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J Cell Sci 2003;116:3611-3622.
23. Kerr MC, Wang JTH, Castro NA, Hamilton NA, Town L, Brown DL, Meunier FA, Brown NF, Stow JL, Teasdale RD. Inhibition of the PtdIns(5) kinase PIKfyve disrupts intracellular replication of Salmonella. EMBO J 2010;29:1331-1347.
24. Gillooly DJ, Raiborg C, Stenmark H. Phosphatidylinositol 3-phosphate is found in microdomains of early endosomes. Histochem Cell Biol 2003;120:445-453.
25. Balla T, Várnai P. Visualization of cellular phosphoinositide pools with GFP-fused protein-domains. In: Bonifacino Al J, editor. Current Protocols in Cell Biology 2009; 42:24.4:24.4.1-24.4.27.
26. Wang X, Mani P, Sarkar DP, Roy-Chowdhury N, Roy-Chowdhury J. Ex vivo gene transfer into hepatocytes. Methods Mol Biol 2009;481:117-140.
27. Sbrissa D, Ikonomov OC, Shisheva A. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J Biol Chem 1999;274:21589-21597.
28. Shisheva A. PIKfyve: partners, significance, debates and paradoxes. Cell Biol Int 2008;32:591-604.
29. Ikonomov OC, Sbrissa D, Shisheva A. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3, 5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem Biophys Res Commun 2009;382:566-570.
30. Jefferies HBJ, Cooke FT, Jat P, Boucheron C, Koizumi T, Hayakawa M, Kaizawa H, Ohishi T, Workman P, Waterfield MD, Parker PJ. A selective PIKfyve inhibitor blocks PtdIns(3, 5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep 2008;9:164-170.
31. Brown JR, Auger KR. Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery. BMC Evol Biol 2011;11:4.
32. Sbrissa D, Ikonomov OC, Filios C, Delvecchio K, Shisheva A. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3, 5)P2 by means of the PIKfyve inhibitor YM201636. Am J Physiol Cell Physiol 2012;303:C436-C446.
33. Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ, Gaullier J-M, Parton RG, Stenmark H. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 2000;19:4577-4588.
34. Sbrissa D, Ikonomov OC, Shisheva A. Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization. J Biol Chem 2002 Feb 22;277:6073-6079.
35. Ikonomov OC, Sbrissa D, Shisheva A. Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve. J Biol Chem 2001 Jul 13;276:26141-26147.
36. +/- mice. J Biol Chem 2011;286:13404-13413.
37. Pryor PR, Reimann F, Gribble FM, Luzio JP. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 2006;7:1388-1398.
38. 2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun 2004;322:1384-1391.
39. Dong X, Shen D, Wang X, Dawson T, Li X, Zhang Q, Cheng X, Zhang Y, Weisman LS, Delling M, Xu H. PI(3, 5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun 2010;1:38.
40. Wong C-O, Li R, Montell C, Venkatachalam K. Drosophila TRPML is required for TORC1 activation. Curr Biol 2012;22:1616-1621.
41. Cheng X, Shen D, Samie M, Xu H. Mucolipins: intracellular TRPML1-3 channels. FEBS Lett 2010;584:2013-2021.
42. Goncalves LA, Vigario AM, Penha-Goncalves C. Improved isolation of murine hepatocytes for in vitro malaria liver stage studies. Malar J 2007;6:169.
43. Lopes VS, Ramalho JS, Owen DM, Karl MO, Strauss O, Futter CE, Seabra MC. The ternary Rab27a-Myrip-Myosin VIIa complex regulates melanosome motility in the retinal pigment epithelium. Traffic 2007;8:486-499.
44. Ikonomov OC, Sbrissa D, Foti M, Carpentier J-L, Shisheva A. PIKfyve controls fluid phase endocytosis but not recycling/degradation of endocytosed receptors or sorting of procathepsin D by regulating multivesicular body morphogenesis. Mol Biol Cell 2003;14:4581-4591.
45. Stuurman N, Edelstein AD, Amodaj N, Hoover KH, Vale RD. Computer control of microscopes using μManager. In: Ausubel Al FM, editor. Current Protocols in Cell Biology 2010; 92:14.20:14.20.1-14.20.17.
46. Shisheva A. PtdIns5P: news and views of its appearance, disappearance and deeds. Arch Biochem Biophys 2013;538:171-180.